New drug approved_Ixazomib

USFDA recently approved Ixazomib, an antineoplastic agent. 

Drug name:
Ixazomib
Innovator:
Millennium Pharms
Brand name:
Ninlaro®
Chemical structure:
1,3,2-dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5dichlorobenzoyl) amino] acetyl]amino]-3-methylbutyl]-5-oxo-
Indications:
Ninlaro® is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
Dosage form:
Capsule; Oral
Strengths:
2.3mg; 3mg; 4mg

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

PHYTOCON 2018 - Commercialization of medicinal plant products: Lab techniques to trade_14 April 2018